CC
IRWD icon

Cipher Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Cipher Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$461K Buy
52,901
+5,353
+11% +$65K 0.21% 172
2023
Q4 		$544K Buy
47,548
+29,420
+162% +$291K 0.18% 189
2023
Q3 		$175K Buy
+18,128
New +$178K 0.12% 262

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Cipher Capital's IRWD Position: Q1 2024 in Review

Cipher Capital increased its Ironwood Pharmaceuticals (IRWD) stake by 11% in Q1 2024, buying an estimated $65K and bringing the position to 52,901 shares worth $461K. The position accounts for 0.21% of the portfolio, ranked #172.

Cipher Capital first reported a position in IRWD in Q3 2023 and has held it in 3 quarters since. The position peaked at $544K in Q4 2023. 261 funds tracked by Wall St. Rank hold IRWD as of Q1 2024.

  • Cipher Capital held 52,901 shares of Ironwood Pharmaceuticals worth $461K as of Q1 2024.
  • Cipher Capital bought 5,353 Ironwood Pharmaceuticals shares in Q1 2024, an estimated $65K.
  • Ironwood Pharmaceuticals made up 0.21% of Cipher Capital's portfolio in Q1 2024, its #172 holding.
  • Cipher Capital first reported a position in Ironwood Pharmaceuticals in Q3 2023 and has held it in 3 quarters since.
  • Cipher Capital's Ironwood Pharmaceuticals position peaked at $544K in Q4 2023.
  • 261 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2024.

Based on Cipher Capital's 13F filing for Q1 2024, filed 15 May 2024.